LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Shanghai Chest Hospital
Shangai, ChinaPublicaciones en colaboración con investigadores/as de Shanghai Chest Hospital (2)
2016
-
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase 2B, open-label, randomised controlled trial
The Lancet Oncology, Vol. 17, Núm. 5, pp. 577-589
2012
-
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 30, Núm. 25, pp. 3084-3092